Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia
NCT02364258Phase 1Completed
- Sponsor
- Children's Mercy Kansas City
- Start
- Jul 2014
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in dyslipidemia comparing Rosuvastatin with Atorvastatin (2 arms). Primary endpoints: Maximum Plasma Concentration (Cmax) of Rosuvastatin at 2 years, Area Under the Curve (AUC) of Rosuvastatin at 2 years and 2 more. Started Jul 2014; status: completed.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02364258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364258.